Sendero Wealth Management’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.79M Sell
41,450
-13,560
-25% -$903K 0.28% 63
2026
Q1
$3.45M Sell
55,010
-10,664
-16% -$743K 0.38% 52
2025
Q4
$4.36M Sell
65,674
-1,749
-3% -$113K 0.48% 44
2025
Q3
$4.54M Buy
67,423
+31,094
+86% +$2.46M 0.53% 39
2025
Q2
$3.17M Buy
36,329
+25,710
+242% +$2.02M 0.4% 53
2025
Q1
$725K Buy
+10,619
New +$867K 0.1% 118

Other funds holding DXCM

Sendero Wealth Management's DXCM Position: Q2 2026 in Review

Sendero Wealth Management reduced its DexCom (DXCM) stake by 25% in Q2 2026, selling an estimated $903K and leaving 41,450 shares worth $2.79M. The position accounts for 0.28% of the portfolio, ranked #63.

Sendero Wealth Management first reported a position in DXCM in Q1 2025 and has held it in 6 quarters since. The position peaked at $4.54M in Q3 2025. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Sendero Wealth Management held 41,450 shares of DexCom worth $2.79M as of Q2 2026.
  • Sendero Wealth Management sold 13,560 DexCom shares in Q2 2026, an estimated $903K.
  • DexCom made up 0.28% of Sendero Wealth Management's portfolio in Q2 2026, its #63 holding.
  • Sendero Wealth Management first reported a position in DexCom in Q1 2025 and has held it in 6 quarters since.
  • Sendero Wealth Management's DexCom position peaked at $4.54M in Q3 2025.
  • 973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Sendero Wealth Management's 13F filing for Q2 2026, filed 4 Aug 2026.